Article
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.
Cancer - 1 Dec 2013
Karagkounis Georgios, Torbenson Michael S, Daniel Hubert D, Azad Nilofer S, Diaz Luis A, Donehower Ross C, Hirose Kenzo, Ahuja Nita, Pawlik Timothy M, Choti Michael A
Abstract excerpt
BACKGROUND: Molecular biomarkers offer the potential for refining prognostic determinants in patients undergoing cancer surgery. Among patients with colorectal cancer, KRAS and BRAF are important biomarkers, but their role in patients undergoing surgical therapy for liver metastases is unknown. In this study, the incidence and prognostic significance of KRAS and BRAF mutations were determined in patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
